Ann Hepatobiliary Pancreat Surg.  2020 May;24(2):168-173. 10.14701/ahbps.2020.24.2.168.

Splenectomy with endotherapy in non-cirrhotic portal fibrosis related portal hypertension: Can it be an alternative to proximal spleno-renal shunt?

• Saluja SS
• Kumar A
• Govind H
• Varshney V
• Khullar R
• Mishra PK

• KMID: 2500801
• DOI: http://doi.org/10.14701/ahbps.2020.24.2.168

Abstract

Backgrounds/Aims
Proximal splenorenal shunt (PSRS) is usually done in symptomatic non-cirrhotic portal fibrosis (NCPF). The outcomes of splenectomy with endotherapy in non-bleeder NCPF patients has not been well studied. We here by aimed to study the post-surgical outcomes on short and long-term basis between PSRS and splenectomy among non-bleeder NCPF patients.
Methods
The consecutive non-bleeder NCPF patients whom underwent either splenectomy or PSRS from 2008 to 2016 were enrolled. The patients were followed up post-surgery clinically and biochemical investigations, Doppler ultrasound and upper gastrointestinal endoscopy were done as required. The peri-operative parameters compared were operative time, blood loss, hospital stay and morbidity. The long-term outcome measures compared were incidence of portal hypertension (PHTN) related bleed, change in grade of varices, shunt patency, shunt complications and thrombosis of spleno-portal axis.
Results
Among 40 patients with non-bleeder status, 24 underwent splenectomy and 16 underwent PSRS. The baseline characteristics including indication of surgery, biochemical investigations and grade of varices were comparable between PSRS and splenectomy. The peri-operative morbidity was not significantly different between two groups. The median follow up duration was 42 months (12-72 months), the decrement in grade of varices was significantly higher in PSRS group (p=0.03), symptomatic PHTN related UGIB was non-significant between PSRS and splenectomy (p=0.5). In PSRS group, 3 (18.3%) patients had shunt thrombosis (n=1) & encephalopathy (n=2) while in splenectomy group two patients developed thrombosis of splenoportal axis.
Conclusions
Splenectomy with endotherapy is alternative to PSRS in non-bleeder NCPF patients with indications for surgery.

Keyword

Non-cirrhotic portal fibrosis; GI bleed; Spleno-renal shunt; Splenectomy; Endotherapy

Reference

1. Khanna R, Sarin SK. 2014; Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 60:421–441. DOI: 10.1016/j.jhep.2013.08.013. PMID: 23978714.

2. Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. 2011; Idiopathic noncirrhotic portal hypertension. Hepatology. 54:1071–1081. DOI: 10.1002/hep.24422. PMID: 21574171.

3. Sarin SK, Agarwal SR. 2002; Extrahepatic portal vein obstruction. Semin Liver Dis. 22:43–58. DOI: 10.1055/s-2002-23206. PMID: 11928078.

4. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. 2002; Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 17:6–16. DOI: 10.1046/j.1440-1746.2002.02596.x. PMID: 11895549.

5. Schouten JN, Nevens F, Hansen B, Laleman W, van den Born M, Komuta M, et al. 2012; Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther. 35:1424–1433. DOI: 10.1111/j.1365-2036.2012.05112.x. PMID: 22536808.

6. Sarin SK, Kumar A. 2006; Noncirrhotic portal hypertension. Clin Liver Dis. 10:627–651. x.DOI: 10.1016/j.cld.2006.08.021. PMID: 17162232.

7. de Franchis R. Baveno VI Faculty. 2015; Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 63:743–752. DOI: 10.1016/j.jhep.2015.05.022. PMID: 26047908.

8. Pal S, Radhakrishna P, Sahni P, Pande GK, Nundy S, Chattopadhyay TK. 2005; Prophylactic surgery in non-cirrhotic portal fibrosis: is it worthwhile? Indian J Gastroenterol. 24:239–242. PMID: 16424619.

9. Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP. STROCSS Group. 2017; The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery. Int J Surg. 46:198–202. DOI: 10.1016/j.ijsu.2017.08.586. PMID: 28890409. PMCID: PMC6040889.

10. Mishra PK, Patil NS, Saluja S, Narang P, Solanki N, Varshney V. 2016; High patency of proximal splenorenal shunt: a myth or reality ? - a prospective cohort study. Int J Surg. 27:82–87. DOI: 10.1016/j.ijsu.2015.12.071. PMID: 26804351.

11. Prasad AS, Gupta S, Kohli V, Pande GK, Sahni P, Nundy S. 1994; Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg. 219:193–196. DOI: 10.1097/00000658-199402000-00011. PMID: 8129490. PMCID: PMC1243121.

12. Rajalingam R, Javed A, Sharma D, Sakhuja P, Singh S, Nag HH, et al. 2012; Management of hypersplenism in non-cirrhotic portal hypertension: a surgical series. Hepatobiliary Pancreat Dis Int. 11:165–171. DOI: 10.1016/S1499-3872(12)60143-X. PMID: 22484585.

13. Sarin SK, Nundy S. 1985; Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver. 5:142–146. DOI: 10.1111/j.1600-0676.1985.tb00229.x. PMID: 4046752.

14. Kumar A, Bhuyan UN, Nundy S. 1989; Glomerulonephritis complicating non-cirrhotic portal fibrosis. J Gastroenterol Hepatol. 4 Suppl 1:271–275. PMID: 2519075.

15. Dash SC, Bhuyan UN, Dinda AK, Saxena S, Agarwal SK, Tiwari SC, et al. 1997; Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. Kidney Int. 52:482–485. DOI: 10.1038/ki.1997.357. PMID: 9264006.

16. Ohnishi K, Saito M, Sato S, Terabayashi H, Iida S, Nomura F, et al. 1987; Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology. 92:751–758. DOI: 10.1016/0016-5085(87)90028-X. PMID: 3817395.

17. Belhamidi MS, Hammi SE, Bouzroud M, Benmoussa M, Ali AA, Bounaim A. 2017; [Role of splenectomy in the treatment of non-cirrhotic portal hypertension: about 3 cases]. Pan Afr Med J. 28:84. French. DOI: 10.11604/pamj.2017.28.84.11712. PMID: 29255554. PMCID: PMC5724939.